When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Whipple disease

Última revisão: 12 Dec 2025
Última atualização: 20 Sep 2023

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • diarrhea
  • weight loss
  • arthralgia
  • supranuclear ophthalmoplegia
Detalhes completos

Outros fatores diagnósticos

  • abdominal pain
  • lymphadenopathy
  • fever
  • steatorrhea
  • anemia
  • skin darkening
  • confusion, memory impairment, altered level of consciousness, or dementia
  • apathy
  • anxiety, depression, hypomania, psychosis, change in personality
  • myoclonic signs
  • seizures
  • nystagmus
  • brisk reflexes, extensor plantar responses, weakness predominating in arm extensors and leg flexors, hypertonia
  • amenorrhea, polydipsia, hyperphagia, decreased libido
  • ataxia
  • headaches
  • oculomasticatory and oculofacioskeletal myorhythmias
  • hemiparesis
  • cranial nerve involvement
  • extrapyramidal movement disorder
  • peripheral neuropathies
Detalhes completos

Fatores de risco

  • age >50 years
  • male sex
  • genetic factors
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • CBC
  • serum albumin
  • serum CRP
  • serum ESR
  • upper GI endoscopy
  • Periodic acid-Schiff (PAS) staining of duodenal biopsies
  • PCR
  • Tropheryma whipplei-specific immunohistochemistry
Detalhes completos

Novos exames

  • electron microscopy
  • culture
  • serology

Algoritmo de tratamento

AGUDA

patients without CNS involvement

patients with CNS involvement

Colaboradores

Autores

Thomas Schneider, MD, PhD

Professor

Medical Department I

Charité - University Medicine Berlin

CBF

Berlin

Germany

Declarações

TS is an author of a number of references cited in this topic.

Verena Moos, PhD

Scientist

Medical Department I

Charité - University Medicine Berlin

CBF

Berlin

Germany

Declarações

VM is an author of a number of references cited in this topic.

Revisores

Stephen G. Baum, MD

Professor of Medicine

Department of Microbiology and Immunology

Albert Einstein College of Medicine

Bronx

NY

Divulgaciones

SGB declares that he has no competing interests.

Chris Huston, MD

Assistant Professor of Medicine

Division of Infectious Diseases

University of Vermont

Burlington

VT

Divulgaciones

CH declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Schneider T, Moos V, Loddenkemper C, et al. Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis. 2008 Mar;8(3):179-90. Resumen

Fenollar F, Puechal X, Raoult D. Whipple's disease. N Engl J Med. 2007 Jan 4;356(1):55-66.

Dobbins WO. Whipple's disease. Springfield, IL: Thomas; 1987.

Louis ED, Lynch T, Kaufmann P, et al. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol. 1996 Oct;40(4):561-8. Resumen

Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology. 2010 Feb;138(2):478-86; quiz 11-2.Texto completo  Resumen

Feurle GE, Moos V, Bläker H, et al. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease. J Infect. 2013 Mar;66(3):263-70. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad